CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates-Reference-Cited by-同舟云学术

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

Published:2011-08-21 Issue:9 Volume:17 Page:1128-1131
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Sullivan Nancy J,Hensley Lisa,Asiedu Clement,Geisbert Thomas W,Stanley Daphne,Johnson Joshua,Honko Anna,Olinger Gene,Bailey Michael,Geisbert Joan B,Reimann Keith A,Bao Saran,Rao Srinivas,Roederer Mario,Jahrling Peter B,Koup Richard A,Nabel Gary J

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2447.pdf

Reference21 articles.

1. Sullivan, N.J. et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424, 681–684 (2003).

2. Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.Y. & Nabel, G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605–609 (2000).

3. Sullivan, N.J. et al. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. PLoS Med. 3, e177 (2006).

4. Jones, S.M. et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 11, 786–790 (2005).

5. Geisbert, T.W. et al. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. J. Virol. 84, 10386–10394 (2010).

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases;Nature Communications;2024-09-03

3. Antibody‐mediated control mechanisms of viral infections;Immunological Reviews;2024-08-20

4. Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse;PLOS Pathogens;2024-06-26

5. Ebola-specific therapeutic antibodies from lab to clinic: The example of ZMapp;Antiviral Research;2024-06